These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 24666617)

  • 1. Impact of dual antiplatelet therapy on outcomes among aspirin-resistant patients following coronary artery bypass grafting.
    Gasparovic H; Petricevic M; Kopjar T; Djuric Z; Svetina L; Biocina B
    Am J Cardiol; 2014 May; 113(10):1660-7. PubMed ID: 24666617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of dual antiplatelet therapy after coronary artery bypass surgery on 1-year outcomes in the Arterial Revascularization Trial.
    Benedetto U; Altman DG; Gerry S; Gray A; Lees B; Flather M; Taggart DP;
    Eur J Cardiothorac Surg; 2017 Sep; 52(3):456-461. PubMed ID: 28387790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of dual antiplatelet therapy after implantation of the first-generation and second-generation drug-eluting stents.
    Yu X; Chen F; He J; Gao Y; Wu C; Luo Y; Zhang X; Zhang Y; Ren X; Lv S
    Coron Artery Dis; 2013 May; 24(3):217-23. PubMed ID: 23425771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effect of dual antiplatelet treatment after off-pump coronary artery bypass grafting.
    López J; Morales C; Avanzas P; Callejo F; Hernández-Vaquero D; Llosa JC
    J Card Surg; 2013 Jul; 28(4):366-72. PubMed ID: 23879339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights.
    van Diepen S; Fuster V; Verma S; Hamza TH; Siami FS; Goodman SG; Farkouh ME
    J Am Coll Cardiol; 2017 Jan; 69(2):119-127. PubMed ID: 28081820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clopidogrel Versus Aspirin as an Antiplatelet Monotherapy After 12-Month Dual-Antiplatelet Therapy in the Era of Drug-Eluting Stents.
    Park TK; Song YB; Ahn J; Carriere KC; Hahn JY; Yang JH; Choi SH; Choi JH; Lee SH; Gwon HC
    Circ Cardiovasc Interv; 2016 Jan; 9(1):e002816. PubMed ID: 26755571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia).
    Campo G; Tebaldi M; Vranckx P; Biscaglia S; Tumscitz C; Ferrari R; Valgimigli M
    J Am Coll Cardiol; 2014 Feb; 63(6):506-12. PubMed ID: 24161321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD
    J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation.
    Musumeci G; Rossini R; Lettieri C; Capodanno D; Romano M; Rosiello R; Guagliumi G; Valsecchi O; Gavazzi A; Angiolillo DJ
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):395-405. PubMed ID: 22109961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial.
    Suh JW; Lee SP; Park KW; Lee HY; Kang HJ; Koo BK; Cho YS; Youn TJ; Chae IH; Choi DJ; Rha SW; Bae JH; Kwon TG; Bae JW; Cho MC; Kim HS
    J Am Coll Cardiol; 2011 Jan; 57(3):280-9. PubMed ID: 21232664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial.
    Costa F; Vranckx P; Leonardi S; Moscarella E; Ando G; Calabro P; Oreto G; Zijlstra F; Valgimigli M
    Eur Heart J; 2015 May; 36(20):1242-51. PubMed ID: 25718355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery.
    Qu J; Zhang H; Rao C; Chen S; Zhao Y; Sun H; Song Y; Liu S; Wang L; Feng W; Wang S; Hu S; Zheng Z
    J Am Heart Assoc; 2021 Jun; 10(11):e020413. PubMed ID: 33998246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual antiplatelet therapy in patients with a long coronary artery lesion over 30 mm: Determinants and impact on prognosis.
    Manchuelle A; Delhaye C; Schurtz G; Sudre A; Hurt C; Bonello L; Puymirat E; Bauters C; Lemesle G
    Arch Cardiovasc Dis; 2015 Apr; 108(4):235-43. PubMed ID: 25682548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study.
    Valgimigli M; Campo G; de Cesare N; Meliga E; Vranckx P; Furgieri A; Angiolillo DJ; Sabatè M; Hamon M; Repetto A; Colangelo S; Brugaletta S; Parrinello G; Percoco G; Ferrari R;
    Circulation; 2009 Jun; 119(25):3215-22. PubMed ID: 19528337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tranexamic Acid in on-pump coronary artery bypass grafting without clopidogrel and aspirin cessation: randomized trial and 1-year follow-up.
    Shi J; Wang G; Lv H; Yuan S; Wang Y; Ji H; Li L
    Ann Thorac Surg; 2013 Mar; 95(3):795-802. PubMed ID: 22959576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
    Une D; Al-Atassi T; Kulik A; Voisine P; Le May M; Ruel M
    Circulation; 2014 Sep; 130(11 Suppl 1):S12-8. PubMed ID: 25200049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of aspirin resistance on outcomes among patients following coronary artery bypass grafting: exploratory analysis from randomized controlled trial (NCT01159639).
    Petricevic M; Kopjar T; Gasparovic H; Milicic D; Svetina L; Zdilar B; Boban M; Mihaljevic MZ; Biocina B
    J Thromb Thrombolysis; 2015 May; 39(4):522-31. PubMed ID: 25095738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study.
    Gwon HC; Hahn JY; Park KW; Song YB; Chae IH; Lim DS; Han KR; Choi JH; Choi SH; Kang HJ; Koo BK; Ahn T; Yoon JH; Jeong MH; Hong TJ; Chung WY; Choi YJ; Hur SH; Kwon HM; Jeon DW; Kim BO; Park SH; Lee NH; Jeon HK; Jang Y; Kim HS
    Circulation; 2012 Jan; 125(3):505-13. PubMed ID: 22179532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
    Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
    Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prehospitalization antiplatelet therapy and outcomes after saphenous vein graft intervention.
    Harskamp RE; Beijk MA; Damman P; Tijssen JG; Lopes RD; de Winter RJ
    Am J Cardiol; 2013 Jan; 111(2):153-8. PubMed ID: 23102882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.